Navigation Links
Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
Date:10/31/2007

projects proforma EPS to be in the range of $1.60 to $1.70.

Kendle will host its third quarter conference call Oct. 31, 2007, at 8:30 a.m. Eastern Time. The call will be broadcast live over the Internet and can be accessed at http://www.kendle.com. A replay of the Webcast will be available at http://www.kendle.com shortly after the call for on-demand replay through 5 p.m. Eastern Time on Nov. 30, 2007.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.

Information provided herein, which is not historical information, su
'/>"/>

SOURCE Kendle
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Woman Delivers Identical Quadruplets
2. No Carrier Necessary: This Drug Delivers Itself
3. Government Delivers On Emergency Medical Training For Rural Doctors
4. Fat Screen Delivers Plant-derived Chemical With Antidiabetic Effects
5. Cuban Healthcare Delivers, Experts Say
6. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
7. Record growth of Soya-based dairy alternatives in Europe
8. Gujarat Records Fall In AIDS Cases
9. Record Number of Countries Contributed to UNFPA in 2005
10. Indonesia Records Another Bird Flu Death
11. British Columbia Has The Best Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...UNTY, Calif., Nov. 21 Album Creati...irm, launches a new program offering big brand mar...aken the large, expensive ad agency process and se... a very hands-on approach," says Matt Parker, Crea... combines experience and proven brand-building tec...
(Date:11/21/2008)...eeting of shareholders to be held on January 8, 20...ll/ - Med-Emerg International Inc. ("MedEmerg") (O...health services, announced today that it has obtai...rt of Justice concerning its previously announced ...o which AIM Health Group Inc. ("AIM") will acquire...
(Date:11/21/2008)...G, Pa., Nov. 21 During...nor Edward G. Rendell today remembered Lieutenant ...er, an important partner in public service, and a ..., , "As the first woman elected lieutenant ... servant," said Governor Rendell. "Her family and ...
(Date:11/21/2008)..., Va., Nov. 21 The Gene...e following statement today from,GPhA President a... Commission,(FTC) roundtable on "Emerging Health ...he mere fact that the FTC is conducting this round...suring that consumers have access to safe and,aff...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...rs have pledged to identify children at risk in ho...ancy stage itself. // Minister Jack McConnell unve...rm - Next Steps to protect such children effective... to improve the identification of these children a...
...iament Wednesday approved a bill prohibiting smoki...hibits smoking in public groups, restaurants and e...f $12.5. It also restricts selling of cigarettes ... 18. Under the bill, an offender will have to pay ...
...ts major Female Health Company (FHC) has received ...le condoms //for India's state-run National AIDS C...sed in NACO's reproductive health and HIV/AIDS pre...ll initially be focused on commercial sex workers ...
...pointed out the alarming incidence of metabolic sy... official statistics, more than 25 million people,...ion face a high risk of heart attack and stroke. ...vernment health officials have stressed the need f...
Other Medicine News:Health News:US Firm To Supply Female Condoms To India 2
(Date:11/19/2008)...if., Nov. 19 Amgen,(Nas...Company, a subsidiary of,Takeda Pharmaceutical Co...nrollment in the Phase 3 MONET1 trial evaluating m... and carboplatin for the first-line treatment of,...en temporarily suspended,following a planned safe...
(Date:11/19/2008)..., Nov. 19 Biotech scientists incre...cology research to better understand the effects o...ems, reports Genetic Engineering & Biotechnol...in figuring out a new compound,s mechanism of acti...gy technique, according to the November 15 issue o...
(Date:11/18/2008)...9 NeuroDiscovery Ltd (AS...r and drug development Company,and Sosei Group C...eading,international biopharmaceutical company, t...urther pivotal pre-clinical efficacy data for NSL-...al therapy for neuropathic pain and has,successfu...
(Date:11/18/2008)...v. 18 Forty-two leading...vember national forum to consider cutting-edge inn...nd national economy from outbreaks of dangerous zo..., , Among those innovations: , , , ...tchen table that detects highly contagious and dan...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Chemical compound present in detergents produce bacteria alterations in agricultural soils 1148 1Chemical compound present in detergents produce bacteria alterations in agricultural soils 1148 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 1New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 3Researchers discover natural herbicide released by grass 1144 1Researchers discover natural herbicide released by grass 1144 2Educational media workshop unites cancer scientists and journalists 5857 1
...st clinical study of,HGS-ETR1 -, ROCKVILLE, Md., A...me Sciences, Inc. today reported that clinical and...ating that its TRAIL receptor,antibodies, HGS-ETR1...gnificant potential for use in the treatment of a ...1 and HGS-ETR2 could offer novel, highly,targeted ...
... - Insmed Inc.,(Nasdaq:INSM) today announced posi...d clinical study of the company,s drug,IPLEX(TM) i...ed,Adipose Redistribution Syndrome (HARS)., Prelim...he,University of California, San Francisco, showed...t in seven patients increased IGF-I,levels 3-fold ...
Other Medicine Technology:Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 2Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 3Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 4Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 5Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: